Capstone — End-to-End Pharmacogenomics & PMx Project — Hands-on

Apply everything learned across pharmacogenomics and pharmacometrics into a guided, end-to-end project. In this capstone, you will frame a PGx–PMx use case, assemble and interrogate datasets, structure a conceptual PK/PD reasoning path, and prepare a clear genotype-to-dose decision-support report with audit-ready documentation.

Capstone — End-to-End Pharmacogenomics & PMx Project

Help Desk · WhatsApp

Session Index

Session 1 — Use-Case Framing & Data Landscape Session 2 — PGx Interpretation & PMx Reasoning Session 3 — Integrated Workflow & Mock Outputs Session 4 — Final Showcase & Audit Trail

Session 1

Fee: Rs 8800

Use-Case Framing & Data Landscape

Selecting a PGx–PMx use case and clinical context

high-impact drug–gene pair indication and line of therapy clear clinical decision question

Mapping the data landscape for the project (conceptual)

PGx results and phenotypes dose, exposure and outcome records basic covariates and comedications

Drafting a one-page project charter

objectives and key questions scope, assumptions and constraints simple milestones and timelines

Session 2

Fee: Rs 11800

PGx Interpretation & PMx Reasoning

Summarising pharmacogene findings for the chosen case

genotype to phenotype translation conceptual use of guideline tiers baseline risk narrative for the patient

Structuring a PK/PD and exposure–response reasoning path

clearance and exposure expectations effect window and toxicity window ideas impact of covariates in plain language

Aligning PGx interpretation with dose and regimen options

candidate starting dose bands when to avoid or switch medicines initial monitoring and follow-up plans

Session 3

Fee: Rs 14800

Integrated Workflow & Mock Outputs

Designing the end-to-end PGx–PMx workflow on paper

from sample and data intake to report key checkpoints and handshakes simple swimlane diagram for teams

Preparing mock analytic and decision-support outputs

tables and plots that summarise exposure PGx-aware dose recommendation block notes for EMR or report integration

Capturing rationale, assumptions and limitations clearly

what data were used and not used strength of evidence narrative when to revisit or update decisions

Session 4

Fee: Rs 18800

Final Showcase & Audit Trail

Presenting the genotype-to-dose recommendation to peers

5–10 minute oral presentation single-slide clinical summary Q&A from a mixed audience

Building a simple audit trail for the project

versioned artefacts and logs list decision and assumption register hand-over note for future work

Deliverables: PGx–PMx project dossier and reflection note

PDF or PPTX dossier 1–2 page written reflection portfolio-ready project summary

PDF

Capstone Pharmacogenomics & PMx Project Training | End-to-End Genotype-to-Dose

Capstone — End-to-End Pharmacogenomics & PMx Project — Hands-on